Omnicell, Inc.
Omnicell, Inc. (Nasdaq: OMCL) provides medication management automation, software, and services to hospitals, health systems, pharmacies, and other healthcare providers. Its solutions include automated medication and supply dispensing systems for nursing units and other points of care; central pharmacy robotics and… From the company’s description.
Over the twelve months to Sep 30, 2026, Omnicell, Inc. reported revenue of $1.24B, up 5.6% from a year earlier, and net income of $44.66M. Its operating margin was 5.2%, and operations generated $186.22M in cash. In fiscal 2025, it reported revenue of $1.18B, up 6.5% from fiscal 2024, and net income of $2.05M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Omnicell, Inc. does
In the company’s own words
Omnicell, Inc. (Nasdaq: OMCL) provides medication management automation, software, and services to hospitals, health systems, pharmacies, and other healthcare providers. Its solutions include automated medication and supply dispensing systems for nursing units and other points of care; central pharmacy robotics and automation for dispensing and sterile IV compounding; and software and analytics for inventory visibility, workflow management, and diversion detection. Omnicell also offers specialty pharmacy and 340B program services, medication-adherence packaging and equipment, and EnlivenHealth digital tools for retail and community pharmacies, including patient engagement and clinical and financial workflows. Professional, technical, and customer success services support implementation and operation of its products. The company organizes its business as one reportable segment. Its solutions serve inpatient, outpatient, retail, long-term care, and other institutional settings in the United States and internationally. Omnicell has more than 30 years of experience providing medication management solutions and offers its OmniSphere intelligence ecosystem across its portfolio.
Company details
- Sector
- Health Care
- Industry (SIC)
- Computer Hardware
- Headquarters
- FORT WORTH, TX
- Fiscal year end
- December
- CIK
- 926326
- SIC
- 3571
Financial performance, year by year
Fiscal 2011–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Omnicell, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Omnicell, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Omnicell, Inc.’s bonds, as funds hold them
Funds report holding 1 issues of Omnicell, Inc.’s debt, $18.91M at market value — what funds hold, not the company’s total debt. Weighted-average coupon 1.00%, maturing 2029 to 2029.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Omnicell, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Omnicell, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Omnicell, Inc.'s last four quarterly filings that the numbers alone won't show?”